“Are JAK inhibitors rewriting the natural history of the disease, and is there any evidence that you can develop a resistance to JAK inhibitors?” asks Patient Power MPN community member, James, in this Ask the Expert segment. Dr. Naveen Pemmaraju of MD Anderson Cancer Center answers both questions, and he comments further on clinical trials as well as other options beyond JAK inhibitors.